Medidata Solutions Inc. (NASDAQ:MDSO) President Vries Glen Michael De sold 7,500 shares of the business’s stock in a transaction on Monday, September 12th. The shares were sold at an average price of $53.70, for a total transaction of $402,750.00. Following the sale, the president now directly owns 950,153 shares in the company, valued at $51,023,216.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Vries Glen Michael De also recently made the following trade(s):

  • On Tuesday, August 9th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The shares were sold at an average price of $54.39, for a total transaction of $407,925.00.
  • On Tuesday, July 12th, Vries Glen Michael De sold 32,500 shares of Medidata Solutions stock. The shares were sold at an average price of $49.25, for a total transaction of $1,600,625.00.

Shares of Medidata Solutions Inc. (NASDAQ:MDSO) opened at 54.95 on Monday. The company has a market capitalization of $3.05 billion, a PE ratio of 141.26 and a beta of 1.21. The firm’s 50-day moving average is $53.94 and its 200-day moving average is $45.58. Medidata Solutions Inc. has a 12-month low of $30.22 and a 12-month high of $56.27.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Wednesday, July 20th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. The company had revenue of $114.60 million for the quarter, compared to analysts’ expectations of $112.39 million. Medidata Solutions had a net margin of 5.29% and a return on equity of 10.32%. The business’s quarterly revenue was up 16.8% compared to the same quarter last year. During the same period last year, the firm posted $0.22 earnings per share. On average, equities research analysts anticipate that Medidata Solutions Inc. will post $1.01 EPS for the current fiscal year.

Several institutional investors have recently made changes to their positions in the company. Mason Street Advisors LLC purchased a new position in shares of Medidata Solutions during the second quarter worth $525,000. Schwab Charles Investment Management Inc. raised its stake in shares of Medidata Solutions by 1.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 189,914 shares of the company’s stock worth $8,902,000 after buying an additional 3,348 shares during the last quarter. Amalgamated Bank raised its stake in shares of Medidata Solutions by 9.3% in the second quarter. Amalgamated Bank now owns 6,365 shares of the company’s stock worth $344,000 after buying an additional 544 shares during the last quarter. Fiera Capital Corp bought a new stake in shares of Medidata Solutions during the second quarter worth approximately $50,760,000. Finally, Arizona State Retirement System raised its stake in shares of Medidata Solutions by 3.1% in the second quarter. Arizona State Retirement System now owns 29,777 shares of the company’s stock worth $1,396,000 after buying an additional 900 shares during the last quarter.

Several analysts have issued reports on MDSO shares. TheStreet raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, August 25th. Deutsche Bank AG upped their price target on shares of Medidata Solutions from $56.00 to $58.00 and gave the stock a “buy” rating in a research note on Tuesday, September 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $60.00 price target (up from $55.00) on shares of Medidata Solutions in a research note on Sunday, July 24th. Morgan Stanley reaffirmed a “buy” rating and issued a $61.00 price target on shares of Medidata Solutions in a research note on Thursday, August 25th. Finally, KeyCorp reaffirmed a “buy” rating and issued a $55.00 price target on shares of Medidata Solutions in a research note on Sunday, May 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $54.09.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

5 Day Chart for NASDAQ:MDSO

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.